UY37626A - Variantes de hppd y métodos de uso - Google Patents

Variantes de hppd y métodos de uso

Info

Publication number
UY37626A
UY37626A UY0001037626A UY37626A UY37626A UY 37626 A UY37626 A UY 37626A UY 0001037626 A UY0001037626 A UY 0001037626A UY 37626 A UY37626 A UY 37626A UY 37626 A UY37626 A UY 37626A
Authority
UY
Uruguay
Prior art keywords
hppd
inhibitors
polypeptides
variations
methods
Prior art date
Application number
UY0001037626A
Other languages
English (en)
Inventor
Marc Linka Dr
Fabien Poree Dr
Bernd Laber Dr
Gudrun Lange Dr
Wayne Coco Dr
Michael Strerath Dr
Ernst Weber Dr
Nikolaus Pawlowski Dr
Sandra Geske
Balven-Ross Heike
Nina Wobst
Christina Thies
Manuel Dubald
Jan Tebbe Dr
Original Assignee
Bayer Cropscience Ag
Bayer Cropscience Lp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Cropscience Ag, Bayer Cropscience Lp filed Critical Bayer Cropscience Ag
Publication of UY37626A publication Critical patent/UY37626A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)

Abstract

En la presente invención, se describen polipéptidos de HPPD y las plantas que los contienen que muestran una tolerancia plena contra uno o más herbicidas inhibidores de HPPD que pertenecen a varias clases químicas. Se diseñan un conjunto de polipéptidos de HPPD mutante que no tienen o solamente tienen una afinidad significativamente reducida a los herbicidas inhibidores de HPPD y, al mismo tiempo, la velocidad de disociación de los inhibidores de HPPD del polipéptido de HPPD mutante aumenta en tal medida que los inhibidores de HPPD se convierten en inhibidores completamente reversibles.
UY0001037626A 2017-03-07 2018-03-07 Variantes de hppd y métodos de uso UY37626A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762468040P 2017-03-07 2017-03-07
EP17160640 2017-03-13

Publications (1)

Publication Number Publication Date
UY37626A true UY37626A (es) 2018-09-28

Family

ID=58277228

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037626A UY37626A (es) 2017-03-07 2018-03-07 Variantes de hppd y métodos de uso

Country Status (2)

Country Link
UY (1) UY37626A (es)
WO (1) WO2018162330A1 (es)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3073828A2 (en) * 2013-11-28 2016-10-05 Bayer CropScience Aktiengesellschaft Use of 2-chloro-3-(methylsulfanyl)-n-(1-methyl-1h-tetrazol-5-yl)-4-(trifluoromethyl)benzamide or its salts for controlling unwanted plants in areas of transgenic crop plants being tolerant to hppd inhibitor herbicides
BR112016020709A2 (pt) * 2014-03-11 2017-10-10 Bayer Cropscience Ag variantes de hppd e métodos de uso

Also Published As

Publication number Publication date
WO2018162330A1 (en) 2018-09-13

Similar Documents

Publication Publication Date Title
UY36898A (es) Variantes de hppd y métodos de uso
CL2018002928A1 (es) Compuestos arilo o heteroarilo sustituidos con amino como inhibidores de ehmt1 y ehmt2.
CL2020001271A1 (es) Inhibidores de kras g12c
EA201692240A1 (ru) Небулайзер, индикаторное устройство и контейнер
UY36026A (es) “variantes de hppd y métodos de uso”.
CL2019000586A1 (es) Composiciones de toxinas clostridiales no proteicas.
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
BR112019000195A2 (pt) composições e métodos relacionados a sistemas celulares terapêuticos que expressam rna exógeno
BR112017008666A2 (pt) anticorpos anti-fgfr2/3 e métodos de uso dos mesmos
EA201691916A1 (ru) Биарильные ингибиторы киназы
CO2018000631A2 (es) Compuestos bicíclicos como inhibidores de atx
EA201790649A1 (ru) Бензилзамещенные индазолы в качестве ингибиторов bub 1
EA201891132A1 (ru) Способы лечения состояний, связанных с masp-2 зависимой активацией комплемента
AR108468A1 (es) POLIPÉPTIDOS DE FUSIÓN CD40L-Fc Y MÉTODOS DE USO DE LOS MISMOS
MX2017003524A (es) Presentacion de aplicacion dividida a traves de dispositivos.
UY37977A (es) Nuevas combinaciones de desfoliantes
MX2019010643A (es) Formas y composiciones de un inhibidor de proteina cinasa 2 activada por la proteina cinasa activada por mitogeno (mk2).
CO2017001601A2 (es) Derivados de 1-acetil-4-((pirazin-2-il) amino)-1,2,3,4-tetrahydroquinolina-6 carboxamida como inhibidores de bromodominio
CL2016003023A1 (es) “compuestos derivados de (bencil-piperazin-1-il)(tetrahidrofuran-carbonil o tetrahidropiran-carbonil) sustituido, moduladores rorg; composición farmacéutica que los comprende; y su uso en el tratamiento de la esclerosis múltiple y espondilitis anquilosante”. pct
CL2020000056A1 (es) Nuevos derivados de xantina sustituidos.
CO2020001325A2 (es) Combinaciones herbicidas sinérgicas
SV2019005811A (es) Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos
UY37626A (es) Variantes de hppd y métodos de uso
UY37627A (es) Variantes de hppd y métodos de uso
MX2019015273A (es) Moduladores de alfa-sinucleinca.